These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8234906)

  • 21. Characterization of vasoactive intestinal peptide receptors in canine liver membranes.
    Kiso T; Ito S; Ohta T; Asano T; Nakazato Y
    Biochem Pharmacol; 1994 Jan; 47(2):241-5. PubMed ID: 8304967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of PHI on vasoactive intestinal peptide receptors and adenylate cyclase activity in lung membranes. A comparison in man, rat, mouse and guinea pig.
    Robberecht P; Tatemoto K; Chatelain P; Waelbroeck M; Delhaye M; Taton G; De Neef P; Camus JC; Heuse D; Christophe J
    Regul Pept; 1982 Oct; 4(5):241-50. PubMed ID: 6294750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating polypeptide receptors in chick cerebral cortex.
    Zawilska JB; Niewiadomski P; Nowak JZ
    J Mol Neurosci; 2003 Apr; 20(2):153-62. PubMed ID: 12794309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heart receptors for VIP, PHI and secretin are able to activate adenylate cyclase and to mediate inotropic and chronotropic effects. Species variations and physiopathology.
    Christophe J; Waelbroeck M; Chatelain P; Robberecht P
    Peptides; 1984; 5(2):341-53. PubMed ID: 6089134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular identification and structural requirement of vasoactive intestinal peptide (VIP) receptors in the human colon adenocarcinoma cell line, HT-29.
    Couvineau A; Rousset M; Laburthe M
    Biochem J; 1985 Oct; 231(1):139-43. PubMed ID: 2998337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of receptors for VIP on pancreatic acinar cell plasma membranes using covalent cross-linking.
    McArthur KE; Wood CL; O'Dorisio MS; Zhou ZC; Gardner JD; Jensen RT
    Am J Physiol; 1987 Mar; 252(3 Pt 1):G404-12. PubMed ID: 2435170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase-activating peptide receptor subtypes in mouse calvarial osteoblasts: presence of VIP-2 receptors and differentiation-induced expression of VIP-1 receptors.
    Lundberg P; Lundgren I; Mukohyama H; Lehenkari PP; Horton MA; Lerner UH
    Endocrinology; 2001 Jan; 142(1):339-47. PubMed ID: 11145597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Actions of vasoactive intestinal peptide and secretin on chief cells prepared from guinea pig stomach.
    Sutliff VE; Raufman JP; Jensen RT; Gardner JD
    Am J Physiol; 1986 Jul; 251(1 Pt 1):G96-102. PubMed ID: 3014896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. VIP regulation of a human pancreatic cancer cell line: Capan-1.
    Ruellan C; Scemama JL; Clerc P; Fagot-Revurat P; Clemente F; Ribet A
    Peptides; 1986; 7 Suppl 1():267-71. PubMed ID: 3018700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vasoactive intestinal polypeptide-related peptides modulate tyrosine hydroxylase gene expression in PC12 cells through multiple adenylate cyclase-coupled receptors.
    Wessels-Reiker M; Basiboina R; Howlett AC; Strong R
    J Neurochem; 1993 Mar; 60(3):1018-29. PubMed ID: 8094740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High affinity peptide histidine isoleucine-preferring receptors in rat liver.
    Paul S; Chou J; Kubota E
    Life Sci; 1987 Nov; 41(21):2373-80. PubMed ID: 2824950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Visualization of vasoactive intestinal peptide receptors in human and guinea pig lung.
    Carstairs JR; Barnes PJ
    J Pharmacol Exp Ther; 1986 Oct; 239(1):249-55. PubMed ID: 3020233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of vasoactive intestinal peptide receptors on rat alveolar macrophages.
    Sakakibara H; Shima K; Said SI
    Am J Physiol; 1994 Sep; 267(3 Pt 1):L256-62. PubMed ID: 7943252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of PACAP receptors and signaling pathways in rabbit gastric muscle cells.
    Murthy KS; Jin JG; Grider JR; Makhlouf GM
    Am J Physiol; 1997 Jun; 272(6 Pt 1):G1391-9. PubMed ID: 9227474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of VIP-and helodermin-preferring receptors on rat platelets.
    Shima K; Sakakibara H; Said SI
    Regul Pept; 1996 Jul; 63(2-3):99-103. PubMed ID: 8837217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of colonic circular smooth muscle cells in culture.
    Ennes HS; McRoberts JA; Hyman PE; Snape WJ
    Am J Physiol; 1992 Sep; 263(3 Pt 1):G365-70. PubMed ID: 1329528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The C-terminus ends of secretin and VIP interact with the N-terminal domains of their receptors.
    Gourlet P; Vilardaga JP; De Neef P; Waelbroeck M; Vandermeers A; Robberecht P
    Peptides; 1996; 17(5):825-9. PubMed ID: 8844773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new type of functional VIP receptor has an affinity for helodermin in human SUP-T1 lymphoblasts.
    Robberecht P; Waelbroeck M; De Neef P; Tastenoy M; Gourlet P; Cogniaux J; Christophe J
    FEBS Lett; 1988 Feb; 228(2):351-5. PubMed ID: 2830146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vasoactive intestinal peptide receptor regulation of cAMP accumulation and glycogen hydrolysis in the human Ewing's sarcoma cell line WE-68.
    Van Valen F; Jürgens H; Winkelmann W; Keck E
    Cell Signal; 1989; 1(5):435-46. PubMed ID: 2561912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stimulation of nitric oxide from muscle cells by VIP: prejunctional enhancement of VIP release.
    Grider JR; Murthy KS; Jin JG; Makhlouf GM
    Am J Physiol; 1992 Apr; 262(4 Pt 1):G774-8. PubMed ID: 1566853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.